Answers are grounded in this paper and cite their sources.
Systematic review finds myofunctional therapy improves breathing and tongue strength in pediatric obstructive sleep apnea, indicating potential therapeutic value despite low certainty evidence.
Purpose To evaluate the effectiveness of myofunctional therapy in pediatric patients diagnosed with OSA. Methods A systematic review was conducted following PRISMA 2020 guidelines and registered in PROSPERO (CRD420251250167). Searches were performed in PubMed, EMBASE, Scopus, and Web of Science, complemented by manual screening. Eligible studies included children aged 4–18 years treated with MFT. Methodological quality was assessed using the NIH tool for observational studies and the PEDro scale for randomized trials. Results Of 86 identified records, four studies were included. Sample sizes ranged from 7 to 133 participants (mean age 7.9 years). Across studies, MFT was associated with reductions in apnea–hypopnea index (AHI) (up to ~ 58% in the largest RCT), improvements in oxygen saturation, and increased tongue strength. However, substantial heterogeneity and variable adherence were observed. Overall certainty of evidence was low according to GRADE. Conclusion Current evidence suggests that myofunctional therapy may improve respiratory and functional outcomes in pediatric OSA. However, due to the limited number of studies, substantial heterogeneity, and the low certainty of evidence, its clinical effectiveness cannot yet be confirmed. Further high-quality randomized controlled trials with standardized protocols and long-term follow-up are required.
No takes yet. Share an insight, caveat, or question.
Avivar-Pardo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: